Psychiatry
Mental health and positive development prevention interventions: overview of systematic reviews.
10 May, 2022 | 10:29h | UTC
Retrospective Cohort Study: Risk of suicide death following electroconvulsive therapy treatment for depression.
10 May, 2022 | 10:30h | UTCRisk of suicide death following electroconvulsive therapy treatment for depression: a propensity score-weighted, retrospective cohort study in Canada – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary: Electroconvulsive Therapy for Suicide Risk in Patients With Depression – Consultant360
Commentary on Twitter
retro cohort study: ECT was associated with a reduced risk of suicide death (csHR=0.53; 0.31–0.92). ECT was also associated with a significantly reduced risk of all-cause mortality (0.75; 0.58–0.97]), but not non-suicide death (0.83; 0.61–1.12) https://t.co/GCG6ZnHXjr
— P𝘧OL (@psychopharmacol) May 2, 2022
Systematic Review: Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression.
6 May, 2022 | 10:37h | UTCRelated:
Discontinuing antidepressants: Pearls and pitfalls.
A method for tapering antipsychotic treatment that may minimize the risk of relapse
Systematic Review: Managing Antidepressant Discontinuation
Randomized controlled trial: preventive cognitive therapy for prevention of depressive recurrence
Mobile phone-based interventions for mental health: A systematic meta-review of 14 meta-analyses of randomized controlled trials.
6 May, 2022 | 10:25h | UTC
Review: Mental stress and its effects on vascular health.
5 May, 2022 | 10:28h | UTCMental Stress and Its Effects on Vascular Health – Mayo Clinic Proceedings
Related:
Psychological Stress and Heart Disease: Fact or Folklore? – The American Journal of Medicine
Sudden Cardiac Death Triggered by an Earthquake – New England Journal of Medicine
Cardiovascular Events during World Cup Soccer – New England Journal of Medicine
Guidelines for discontinuation of antipsychotics in patients who recover from first-episode schizophrenia spectrum disorders.
29 Apr, 2022 | 08:10h | UTC
Cohort Study: Neurocognitive development in children at familial high risk of schizophrenia or bipolar disorder.
29 Apr, 2022 | 08:07h | UTCNeurocognitive Development in Children at Familial High Risk of Schizophrenia or Bipolar Disorder – JAMA Psychiatry (link to abstract – $ for full-text)
Commentary: Children at Risk for Schizophrenia Show Early Neurocognitive Deficits – Psychiatric News Alert
Systematic Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.
28 Apr, 2022 | 10:33h | UTC
M-A of randomized trials: telehealth versus face-to-face psychotherapy for less common mental health conditions.
28 Apr, 2022 | 07:56h | UTC
Commentary on Twitter
https://twitter.com/hannahgrnwd/status/1503154965749329924
Longitudinal associations of mental disorders with dementia: 30-year analysis of 1.7 million New Zealand citizens.
27 Apr, 2022 | 07:51h | UTCNews Release: Mental disorders may increase risk for subsequent dementia – University of Michigan
Commentary: Mental Disorders Tied to Subsequent Dementia Onset – HealthDay
Commentary on Twitter
In this longitudinal population-register study of 1.7 million New Zealand citizens, individuals with #mentalhealth disorders had elevated risk for #dementia when followed up years later. https://t.co/kkOUOnHEXE
— JAMA Psychiatry (@JAMAPsych) April 15, 2022
Cohort Study: Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations.
26 Apr, 2022 | 08:21h | UTCNews Release: Study suggests association between severe COVID-19 and long-term mental health outcomes 16 months after an illness – Lancet
Commentary: Lasting depression and anxiety can follow severe case of Covid – NBC News
Commentary on Twitter (thread – click for more)
https://twitter.com/COVIDMENT/status/1513511696979329024
RCT: Effectiveness of cognitive behavioral therapy–based intervention in preventing gaming disorder and unspecified internet use disorder in adolescents.
26 Apr, 2022 | 07:42h | UTCCommentaries:
The Case for Prevention Research in Adolescent-Onset Mental Illness—Game On! – JAMA Network Open
Commentary on Twitter
This RCT of at-risk high school students showed that a short school-based prevention program can reduce gaming disorder and internet use disorder symptoms. https://t.co/L9VhwaRVDG pic.twitter.com/Ix8WzUBSSZ
— JAMA Network Open (@JAMANetworkOpen) February 18, 2022
Study examines patient recovery 10 years after first-episode psychosis.
26 Apr, 2022 | 07:35h | UTCStudy Examines Patient Recovery 10 Years After First-Episode Psychosis – Psychiatric News Alert
NICE Guideline | Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults.
25 Apr, 2022 | 01:11h | UTC
Cohort Study: Association of the 2020 US presidential election with hospitalizations for acute cardiovascular conditions.
25 Apr, 2022 | 01:07h | UTCRelated:
Psychological Stress and Heart Disease: Fact or Folklore? – The American Journal of Medicine
Sudden Cardiac Death Triggered by an Earthquake – New England Journal of Medicine
Cardiovascular Events during World Cup Soccer – New England Journal of Medicine
Commentary from the author on Twitter (thread – click for more)
Found 42%⬆️in heart attacks days after 2020 US Presidential election ! Our study in 6,396,830 adults across California @JAMANetworkOpen https://t.co/4ikeNiWqkB with @MMeffordPhD & collaboration @HarvardChanSPH
Let's not underestimate the impact of emotional stress🔥on❤️
🧵 pic.twitter.com/GVohHz1iGU— Jamal Rana, MD (@JamalRanaMD) April 20, 2022
Guideline: Substance use disorder in the anesthetist.
25 Apr, 2022 | 00:39h | UTC
Anticholinergic medications and dementia: should we be worried?
25 Apr, 2022 | 00:14h | UTCCommonly-prescribed drugs and dementia: should we be worried? – Evidently Cochrane
Original Review:
Related:
How well do you know your anticholinergic (antimuscarinic) drugs? – Therapeutics Initiative
Anticholinergic drugs and risk of dementia: case-control study – The BMJ
Commentary on Twitter
Commonly-prescribed drugs & dementia: should we be worried? https://t.co/pvWxT6q48Z A @CochraneUK blog: Jodi Watt (a researcher @UofGlasgow) explores the @CochraneDCIG evidence on whether #anticholinergics might increase people’s risk of future memory problems, or even #dementia
— The Cochrane Library (@CochraneLibrary) April 22, 2022
RCT: Efficacy of augmentation of cognitive behavioral therapy with transcranial direct current stimulation for depression.
24 Apr, 2022 | 23:56h | UTCEfficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression: A Randomized Clinical Trial – JAMA Psychiatry (free for a limited period)
Author Interview: Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation – JAMA
Commentary on Twitter
This randomized controlled trial found that enhancing #CBT with non-invasive brain stimulation in a group setting was feasible, but not superior to sham or psychotherapy alone. Study defines a framework for future endeavors. https://t.co/LldAPNKTB3 pic.twitter.com/G8R9EVWshv
— JAMA Psychiatry (@JAMAPsych) April 20, 2022
UK drug regulator advises patients and doctors against the use of Pregabalin during pregnancy due to a possible increased risk of congenital malformations.
22 Apr, 2022 | 09:31h | UTCSee also: Pregabalin and risks in pregnancy – Medicines and Healthcare products Regulatory Agency
Source: Avoid prescribing pregabalin during pregnancy if possible, says UK drug regulator – The BMJ ($)
Commentary on Twitter
The Medicines and Healthcare Products Regulatory Agency (@MHRAgovuk) has strengthened its warning about avoiding pregabalin during pregnancy after new data showed an increased risk of major congenital malformations associated with the drug https://t.co/ghGvqCqA0C
— The BMJ (@bmj_latest) April 22, 2022
Video: Here’s what we know about COVID-19’s impact on the brain.
19 Apr, 2022 | 02:22h | UTCHere’s what we know about COVID-19’s impact on the brain – Science
Related:
SARS-CoV-2 is associated with changes in brain structure in UK Biobank – Nature
Nervous system consequences of COVID-19 – Science
The COVID generation: how is the pandemic affecting kids’ brains? – Nature
Assessment of Cognitive Function in Patients After COVID-19 Infection – JAMA Network Open
M-A: Global prevalence of post COVID-19 condition or long COVID.
19 Apr, 2022 | 02:18h | UTCCommentary: Global data reveal half may have long COVID 4 months on – CIDRAP
Commentary on Twitter (thread – click for more)
🚨The so far largest meta-analysis of more than 1.5 million infected individuals puts the global prevalence of #LongCovid at 43%. Some additional key findings. 🧵https://t.co/XGu23MV3Ra
1/— Jonas R. Kunst (@kunstjonas.bsky.social) (@KunstJonas) April 17, 2022
Cohort Study: Association of treatment with antipsychotics, antidepressants, or both with movement disorders and seizures among children and adolescents with depression.
19 Apr, 2022 | 01:50h | UTC
Commentary on Twitter
In this cohort study, adjunctive antipsychotics with antidepressants were associated with movement disorders and seizures compared with antidepressant monotherapy in children and adolescents with depression. https://t.co/3SVKEThwkR
— JAMA Network Open (@JAMANetworkOpen) April 15, 2022
Commentary: Loneliness and health.
18 Apr, 2022 | 10:16h | UTCLoneliness and health – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Related:
The prevalence of loneliness across 113 countries: systematic review and meta-analysis – The BMJ
Social Isolation and Loneliness – World Health Organization
Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020 – JAMA
Commentary on Twitter
In this Comment, Louise Hawkley discusses associations of #Loneliness with increased mortality and disease risk, and that a multi-level approach including individuals, community organizations and society is needed to reduce loneliness.@NORCNewshttps://t.co/CzP5fR6G0n pic.twitter.com/X3use2Aybe
— Nature Reviews Disease Primers (@DiseasePrimers) April 14, 2022
M-A: Association between physical activity and risk of depression.
14 Apr, 2022 | 08:35h | UTCCommentary: Exercise Is Powerful Medicine for Depression – HealthDay
Commentary on Twitter
Meta-analysis found that adults meeting physical activity recommendations had 25% lower risk of #depression compared with adults reporting no #physicalactivity. https://t.co/LITlo954lB
— JAMA Psychiatry (@JAMAPsych) April 13, 2022
Cross-sectional study: The use of Selective Serotonin Reuptake Inhibitors is associated with a reduction in measured movements.
14 Apr, 2022 | 08:32h | UTC
Commentary on Twitter
This cross-sectional study found SSRI use was associated with a reduction in measured movements, highlighting the utility of passively collected data for exploring and characterizing adverse drug effects. https://t.co/54ZngDdt8u
— JAMA Network Open (@JAMANetworkOpen) April 7, 2022